Ganaxolone

加那索龙

Report date: 2026/05/28 20:00:21
NME

Base Information

Drug NameGanaxolone
Drug Alias NameGanaxolone IV加奈索酮GanaxolonaGanaxolonumGanaxalone IV +[10] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGamma-aminobutyric acid A receptor modulators
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsCDKL5 deficiency disorderStress Disorders, Post-TraumaticDepressive Disorder +[21] 
Global Approved IndicationsCDKL5 deficiency disorderSeizuresEpileptic Syndromes +[4] 
Approved Indications in ChinaCDKL5 deficiency disorderSeizures
Original Approved Country/TerritoryUnited States
Original Approved Date2022/03/18
Country/TerritoryCzechiaBelgiumBulgaria +[23] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPurdue Pharma
China Registration ClassN/A

Develop Information

Active CompaniesAltasciences CDMO Philadelphia LLCTenacia Biotechnology (Shanghai) Co LtdMarinus Pharmaceuticals Emerald Ltd +[6] 
Inactive CompaniesNational Institute On Drug Abuse
Active IndicationsCDKL5 deficiency disorderStatus EpilepticusSeizures +[7] 
Inactive IndicationsStress Disorders, Post-TraumaticDepressive DisorderMood Disorders +[14] 

Other Information

ATC CodeN03A
Related LinksWikipediaDrugBankKEGG